Ira D Glick
Academic Appointments
- Emeritus Faculty-Med Ctr Line, Psychiatry & Behavioral Science - Psychopharmacology
Key Documents
Contact Information
- Academic Offices
Personal Information Email
Professional Overview
Administrative Appointments
- Acting Deputy Chief of Staff and Chief of Psychiatry, Palo Alto Veterans, Stanford University School of Medicine & Stanford University Hospital (1995 - 1996)
- Director of Inpatient & Partial Hospitalization Services, Stanford University School of Medicine & Stanford University Hospital (1993 - 2000)
- Director, Schizophrenia Research Clinic, Stanford University School of Medicine & Stanford University Hospital (1993 - present)
- Professor of Psychiatry & Behavioral Sciences, Stanford University School of Medicine (1993 - present)
- Senior Science Advisor to the Director, National Institute of Mental Health, Rockville, MD, 80% (1988 - 1990)
- Associate Medical Director, Payne Whitney Clinic, Dept. of Psychiatry, The New York Hospital- Cornell Medical Center (1978 - 1993)
Honors and Awards
- Skull & Key Award, Dickinson College (1953-1954)
- National Foundation Medical Student Fellowship, Dept. of Physical Medicine & Rehabilitation, New York Medical College (Summer) (1959)
- Dept. of Psychiatry, New York Medical College (Summer), National Institute of Mental Health Research Training Grant (1960)
- Stephen P. Jewett Award ., Dept. of Psychiatry, New York Medical College (1961)
- Army Commendation Medal, U.S. Army Hospital, Ft. Gordon, Georgia (1968)
- Career Teacher in Psychiatry, National Institute of Mental Health, MH-12450 (1971-1973)
Professional Education
| B.S: | Dickinson College, Carlisle,, . (1957) |
| M.D: | New York Medical College (1961) |
| Rotating Internship: | Beth Israel Hospital, New York, (1962) |
| Psychiatry Residency: | Hillside Hospital, Glen Oaks,NY (1963) |
| Psychiatry Residency: | Mt. Zion Hospital, San Francisco (1964) |
| Psychiatry Residency: | Hillside Hospital (1964) |
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Schizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.
Publications
- Central nervous system drug development, basic, and clinical research: thinking outside the box. J Clin Psychopharmacol. 2011; (5): 553-4
- Inpatient psychiatric care in the 21st century: the need for reform. Psychiatr Serv. 2011; (2): 206-9
- The role of the family and improvement in treatment maintenance, adherence, and outcome for schizophrenia. J Clin Psychopharmacol. 2011; (1): 82-5
- A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive. J Clin Psychopharmacol. 2009; (3): 267-71
- Clinical trials design lessons from the CATIE study. Am J Psychiatry. 2009; (11): 1222-8
- Onset and persistence of antipsychotic response in patients with schizophrenia. J Clin Psychopharmacol. 2009; (6): 542-7
Help